YI 111 ADS (N Shares)

111, Inc. Announces Management and Board Changes

111, Inc. Announces Management and Board Changes

SHANGHAI, China, Jan. 18, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading integrated online and offline healthcare platform in China, today announced that Mr. Weihao Xu has resigned as Chief Financial Officer and director for personal reasons.

The Company has begun a process to appoint a successor to Mr. Xu and a further announcement will be made in due course. Mr. Xu will stay until March 7, 2019 to help with the transition.

“I would like to thank Weihao for his substantial contribution to the Company and, in particular, his extensive role in our successful initial public offering and listing on Nasdaq last September,” commented Mr. Junling Liu, Chairman and Chief Executive Officer of 111. “We wish him great success in his future endeavors.”

“I am fortunate to have been part of the success of 111 during a truly remarkable time for both the Company and the healthcare industry in China. I look forward to seeing 111’s continued success in the years ahead,” stated Mr. Xu.

About 111, Inc.

111, Inc. (NASDAQ: YI) (“111” or the “Company”) is a leading integrated online and offline healthcare platform in China. The Company provides hundreds of millions of consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy and indirectly through its offline pharmacy network. 111 also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation and electronic prescription services. In addition to providing direct services to consumers through its online retail pharmacy, 111 also enables offline pharmacies to better serve their customers. The Company’s online wholesale pharmacy, 1 Drug Mall, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. The Company’s new retail platform, by integrating the front and back ends of the pharmaceutical supply chain, has formed a smart supply chain, which transforms the flow of pharmaceutical products to pharmacies and modernizes how they serve their customers.

For more information on 111, please visit

For more information, please contact:

111, Inc.

Christensen

In China

Mr. Christian Arnell

Phone: 8

E-mail:

In US 

Ms. Linda Bergkamp

Phone:

Email:

EN
18/01/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on 111 ADS (N Shares)

Robert Sassoon
  • Robert Sassoon

A Start-Up That Is Delivering Revenue and Profit

We hosted CEO and Co-Founder Junling Liu for a fireside chat on July 18, 2024. The discussion included an overview of 111’s business model, its strategic priorities, and target milestones in the short and longer term. Liu also described the competitive landscape, explaining how the company differentiates itself from the competition, and the market opportunity that presents itself to 111. This report contains a transcript of the conversation, which can be accessed on demand. The link is accessibl...

Robert Sassoon
  • Robert Sassoon

Initiating Coverage: A Leader in China's Digital Health Revolution

111 operates one of China’s most innovative B2B tech-enabled healthcare platforms. Stewarded by an innovative technology leadership team with supply chain management expertise, 111 is one of China’s leading B2B tech-enabled healthcare platforms, operating in an industry where barriers to entry are quite formidable for new entrants. 111’s comprehensive pharmaceutical supply chain ecosystem. 111 has developed an evolving digitalized model with the mission to reshape the entire value chain of China...

 PRESS RELEASE

111 Announces Changes to its Board of Directors

111 Announces Changes to its Board of Directors SHANGHAI, China, May 16, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that Dr. Leon Lian Yong Chen has been appointed as a new member to the board of directors. Meanwhile, Mr. Harry Chi Hui will no longer serve as a director for personal reasons. Both changes will be effective immediately. Dr. Chen is CEO and a founding partner of 6 Dimensions Capital, a major healthcare investment firm with coverage across China and the United States...

 PRESS RELEASE

111, Inc. Announces First Quarter 2019 Unaudited Financial Results

111, Inc. Announces First Quarter 2019 Unaudited Financial Results SHANGHAI, China, May 16, 2019 (GLOBE NEWSWIRE) -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the first quarter ended March 31, 2019. First Quarter 2019 Highlights Net revenues were RMB655.6 million (US$97.7 million), representing an increase of 98.5% year-over-year. Operating expenses1 were RMB139.8 million (US$20.8 million), representing an increase of 67.8% year-over-year. Operating expenses a...

 PRESS RELEASE

111, Inc. to Attend the HSBC 6th Annual China Conference in Shenzhen M...

111, Inc. to Attend the HSBC 6th Annual China Conference in Shenzhen May 15-17, 2019 SHANGHAI, China, May 13, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that the Company will participate in the HSBC 6th Annual China Conference in Shenzhen May 15-17, 2019. Dr. Gang Yu, Co-Founder and Executive Chairman of 111, is scheduled to participate in a panel discussion on China Pharmaceuticals: distribution trends and the role of new platforms on May 16. Dr. Yu will also be available to meet ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch